Cigna Group $CI Stake Boosted by Opal Capital LLC

Opal Capital LLC boosted its holdings in Cigna Group (NYSE:CI) by 19.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,801 shares of the health services provider’s stock after purchasing an additional 4,178 shares during the quarter. Cigna Group makes up about 1.2% of Opal Capital LLC’s investment portfolio, making the stock its 24th largest holding. Opal Capital LLC’s holdings in Cigna Group were worth $6,882,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its stake in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares during the period. Sivia Capital Partners LLC boosted its stake in Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after acquiring an additional 109 shares during the period. NewEdge Advisors LLC boosted its stake in Cigna Group by 4.5% in the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after acquiring an additional 958 shares during the period. Treasurer of the State of North Carolina grew its holdings in shares of Cigna Group by 16.6% during the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after purchasing an additional 21,173 shares during the last quarter. Finally, Osterweis Capital Management Inc. bought a new position in shares of Cigna Group during the second quarter valued at approximately $163,000. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on CI shares. Barclays downgraded Cigna Group from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $310.00 to $304.00 in a report on Tuesday, May 26th. Guggenheim upped their price objective on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Royal Bank Of Canada increased their target price on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. The Goldman Sachs Group raised their target price on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their price target for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $338.80.

Cigna Group Stock Performance

CI stock opened at $301.79 on Wednesday. The company has a 50-day simple moving average of $286.36 and a 200 day simple moving average of $280.96. The company has a market capitalization of $79.83 billion, a P/E ratio of 12.79, a PEG ratio of 1.12 and a beta of 0.29. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter last year, the company earned $6.74 EPS. Cigna Group’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts predict that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.